Could a daily brain zap ease Parkinson's tremors from home?
NCT ID NCT07182058
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a non-invasive device called Sphere V3.0 that delivers gentle electrical pulses to the scalp to improve movement problems in Parkinson's disease. Thirty adults with Parkinson's will use the device at home for 13 minutes each weekday for 3 weeks, then be monitored for 3 more weeks. All assessments are done virtually via video calls, and everyone receives the active treatment—there is no placebo group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcranial electrical stimulation device (Sphere V3.0)
- What this could lead to
- If it works, this could offer a convenient, at-home way to ease movement problems like tremor and stiffness in Parkinson's disease.
- What could go wrong
- This is an early-phase trial with only 30 people and no placebo group, so results may not be conclusive. The device may not provide lasting benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
U LLC Headquarters
RECRUITINGCleveland, Ohio, 44124, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Parkinson's pain: could a new Add-On drug bring relief?
- Could your own bone marrow cells help fight Parkinson's?
- Could gut microbes hold clues to Parkinson's?
- Brain implant for Parkinson's may raise fall risk — a study investigates
- Could hand exercises sharpen the mind in Parkinson's?
- Which balance test best predicts falls in Parkinson's? a head-to-head comparison